Zinc

It depends on your use case. For general maintenance and daily supplementation, zinc picolinate or zinc bisglycinate offer good absorption and excellent tolerability at reasonable cost — most users should default to one of these at 15-30 mg daily. Zinc citrate is a reasonable cheaper alternative. For treating active cold symptoms with lozenges, zinc acetate or zinc gluconate specifically — these forms release ionic zinc in the oropharynx; other forms don't work. For high-dose supplementation (40+ mg daily for clinical indications like AMD or acne), zinc monomethionine (OptiZinc) is often preferred for tolerability. For clinical deficiency repletion under medical supervision, zinc sulfate is the pharmaceutical standard. Zinc oxide is widely sold cheaply but poorly absorbed orally — useful topically (diaper cream, sun protection) but a waste of money as an oral supplement. Zinc picolinate at 20-30 mg with food is the best starting default for most healthy adults.

Yes, if you are taking 30+ mg zinc daily for more than 3 months, or if you are using an AREDS-style AMD formula with 25-80 mg zinc. Zinc and copper compete for intestinal absorption, and chronic high-dose zinc induces copper deficiency, producing anemia, neutropenia, and neurological symptoms. The standard ratio is 1 mg copper per 15 mg zinc, or 2 mg copper per 25-40 mg zinc. Many quality zinc products at doses ≥25 mg include copper in the formulation — check the label. If your product does not include copper, add copper bisglycinate or copper gluconate 1-2 mg daily (taken at a different time of day to maximize absorption of both). For maintenance doses of zinc at 15-25 mg without a specific indication, separate copper supplementation is not required short-term but is worth considering for chronic use. Monitor for anemia, unexplained fatigue, or neurological symptoms with any chronic high-dose zinc regimen; these can indicate copper deficiency from zinc overload.

Yes, when used correctly. Hemilä's Cochrane meta-analyses (PMID 21328251, 33839725) demonstrate that zinc lozenges reduce cold duration by approximately 33-40% when used properly. Requirements for efficacy: (1) zinc acetate or zinc gluconate form specifically — not citrate, picolinate, or bisglycinate; (2) minimum 75 mg elemental zinc per day, typically as 9-18 mg per lozenge every 2-3 hours during waking hours; (3) start within 24 hours of first cold symptom, earlier is better; (4) continue for 5-10 days or until symptoms resolve; (5) dissolve slowly in the mouth (do not chew or swallow whole) to maximize oropharyngeal contact time. Limitations: produces unpleasant metallic taste; causes nausea in 40-60% of users; only effective for rhinovirus colds, not other respiratory viruses; does not prevent colds, only shortens them. Despite these caveats, the mechanism is well-documented (zinc inhibits rhinovirus 3C protease and viral replication), and for users who tolerate the side effects, the reduction in illness duration is meaningful. Oral capsule zinc at standard maintenance doses does not work for cold treatment — the mechanism requires direct oropharyngeal contact via lozenge dissolution.

Only if you're zinc-deficient. In zinc-deficient men, supplementation normalizes testosterone and improves sperm parameters (Prasad PMID 8674032; Kilic PMID 17063431). In zinc-replete men, additional zinc does not further raise testosterone — the marketing of zinc supplements as testosterone boosters for already healthy men is misleading. Who is likely deficient? Vegetarians and vegans, older men, alcoholics, men on chronic PPIs or ACE inhibitors, men with GI malabsorption conditions, men with chronic kidney disease. Population studies suggest 30-40% of American men have marginal zinc status due to dietary patterns, so some proportion of men will respond. If you suspect hypogonadism: check serum testosterone and also consider serum zinc (though serum zinc is insensitive — a normal value doesn't exclude deficiency). For men with clinical hypogonadism, zinc 25-50 mg daily for 3-6 months is reasonable adjunctive therapy alongside medical workup; if testosterone normalizes with zinc alone, you were deficient. For healthy men at 25-35 years of age with normal testosterone, zinc supplementation will not increase testosterone further.

Yes, with decent evidence. Sadeghian's meta-analysis (PMID 31886414) of 14 RCTs found that oral zinc at 30-50 mg elemental zinc daily reduces inflammatory acne lesion count by 40-50% over 8-12 weeks. Effect sizes are comparable to oral antibiotics without the resistance or GI microbiome concerns. Zinc appears to work through multiple mechanisms: reduced sebum production, anti-inflammatory effects on acne-involved T cells, antimicrobial effects on Cutibacterium acnes, and improved skin barrier function. Protocol: zinc picolinate, bisglycinate, or monomethionine at 30-50 mg daily for 8-12 weeks minimum. Often combined with NAC 600-1200 mg, omega-3 2 g, and vitamin D 2000-4000 IU. If combining with topical therapy (tretinoin, benzoyl peroxide), synergistic effects are likely. If using oral zinc long-term (>3 months), add copper 1-2 mg daily. For severe or nodulocystic acne, zinc is unlikely to be adequate monotherapy; standard dermatology pharmacotherapy (isotretinoin, topical retinoids, hormonal therapy in women) remains first-line, with zinc as adjunct.

At standard doses (15-30 mg daily), yes — indefinite daily zinc supplementation is well-tolerated and has an excellent safety record. The key caveats: (1) doses ≥30 mg for more than 3-6 months require copper co-supplementation to prevent copper deficiency; (2) doses >40 mg daily should ideally include copper and periodic CBC monitoring; (3) very high doses (>100 mg daily) for extended periods have been associated with increased advanced prostate cancer risk in some observational data and should be avoided except for specific indications under medical supervision. For maintenance at 15-25 mg daily with food, chronic indefinite use in healthy adults is safe. Monitor for warning signs that would suggest copper deficiency: unexplained anemia, neutropenia, easy bruising, neurological symptoms (numbness, weakness, gait disturbance). These require stopping zinc and supplementing copper. Routine labs for healthy users on moderate zinc doses are not required; annual CBC is reasonable for users on 30+ mg daily chronically.

Best absorption is on empty stomach, but this causes nausea in 30-50% of users at therapeutic doses. Practical compromise: take with a light snack containing some protein (not a heavy meal, not true empty stomach). For maintenance doses of 15-25 mg, taking with dinner or at bedtime is usually well-tolerated. For higher doses, divide into 2 doses (morning and evening with meals). Avoid taking zinc with: coffee or tea (tannins bind zinc), high-calcium meals or dairy (reduced absorption), high-phytate grains or legumes in the same meal (whole grain toast, beans, nuts). Separate from these by 1-2 hours if possible. Separate zinc from iron supplements by 2+ hours, from tetracycline/fluoroquinolone antibiotics by 2-4 hours, and from levothyroxine by 4+ hours (levothyroxine in morning fasted, zinc in evening). Zinc bisglycinate and picolinate are generally the best-tolerated forms; zinc sulfate is the most GI-irritating. If nausea persists despite food and form optimization, reduce the dose.

Probably not for outright deficiency, but possibly for optimization. Omnivores in developed countries generally meet the RDA (8-11 mg daily) through dietary sources — red meat, shellfish (especially oysters, which are extraordinarily zinc-dense at 70 mg per 100g), poultry, eggs, and dairy. If you regularly eat meat or shellfish, you are unlikely to be deficient. Optimization context matters: older adults (>60) have reduced zinc absorption even on adequate diets; heavy exercisers lose zinc through sweat; heavy alcohol users lose zinc through multiple mechanisms; chronic ACE inhibitor or thiazide users lose zinc through increased urinary excretion; chronic PPI users may have impaired zinc absorption. For these populations, supplementation at 15-25 mg daily is reasonable insurance. For vegetarians and especially vegans, zinc supplementation is strongly recommended because plant sources (legumes, whole grains, nuts, seeds) are high in phytate which dramatically reduces zinc bioavailability; RDA effectively doubles for plant-based diets. For otherwise healthy omnivores under 50 with varied diets, zinc supplementation is optional — modest benefits at best and mostly insurance.

Primarily differences in bioavailability, tolerability, and intended use. Zinc sulfate: cheapest, pharmaceutical-grade, most GI-irritating; used for high-dose clinical deficiency repletion. Zinc gluconate: widely available, moderate tolerability, good for cold lozenges (releases ionic zinc in oropharynx). Zinc picolinate: good absorption via amino acid-like transport, well-tolerated, reasonable cost; excellent default for daily supplementation. Zinc bisglycinate (chelated): very well-tolerated due to reduced GI irritation from chelated form, claims of superior bioavailability (mixed evidence); good default for sensitive stomachs. Zinc citrate: well-tolerated, adequate absorption, inexpensive. Zinc acetate: preferred for cold lozenges, releases ionic zinc effectively in oropharynx. Zinc monomethionine (OptiZinc): chelated with methionine, good bioavailability, well-tolerated at higher doses. Zinc oxide: poorly absorbed (~10%); useful topically, wasteful orally. For practical purposes: default to zinc picolinate or bisglycinate at 15-30 mg daily for maintenance; use zinc acetate or gluconate lozenges for colds; use higher-dose zinc monomethionine or sulfate under medical supervision for specific clinical indications.

Yes, and the mechanism is interesting. Quercetin is a zinc ionophore — it facilitates zinc transport across cell membranes, increasing intracellular zinc concentrations. Since zinc's antiviral effect (particularly against rhinovirus and in cell culture against many RNA viruses) requires elevated intracellular zinc, quercetin's ionophore activity amplifies zinc's biological effects. During COVID-19, zinc + quercetin was widely promoted based on this rationale plus in vitro data suggesting SARS-CoV-2 sensitivity to zinc inhibition. However, clinical trials of zinc for COVID-19 outcomes have been largely negative (Thomas 2021 PMID 33523167), so don't expect dramatic benefit for that indication. For general immune support and during seasonal cold/flu exposure, zinc 30 mg + quercetin 500-1000 mg daily is reasonable and low-risk. The combination does not replace evidence-based cold prevention measures (vaccination, hygiene, avoiding sick contacts). For active cold symptoms, zinc lozenges are superior to oral zinc + quercetin because the mechanism requires direct oropharyngeal contact. Note that quercetin has some minor drug interactions (CYP3A4 inhibition); review with your pharmacist if on complex medication regimens.